Path ID: DB00623_MESH_D012559_2
Concepts
| Identifier | Name | Type |
|---|---|---|
| MESH:C017610 | fluphenazine enanthate | Drug |
| UniProt:P14416 | dopamine D2 receptor | Protein |
| GO:0061527 | dopamine secretion, neurotransmission | BiologicalProcess |
| UBERON:0001017 | central nervous system | GrossAnatomicalStructure |
| InterPro:IPR022423 | Neurohypophysial hormone | GeneFamily |
| HP:0000708 | Behavioral abnormality | PhenotypicFeature |
| MESH:D012559 | Schizophrenia | Disease |
Relationships
NOTE: predicates are annotated in Biolink Model (v1.3.0)
| Subject | Predicate | Object |
|---|---|---|
| Fluphenazine Enanthate | DECREASES ACTIVITY OF | Dopamine D2 Receptor |
| Dopamine D2 Receptor | POSITIVELY CORRELATED WITH | Dopamine Secretion, Neurotransmission |
| Dopamine Secretion, Neurotransmission | LOCATED IN | Central Nervous System |
| Central Nervous System | CORRELATED WITH | Neurohypophysial Hormone |
| Neurohypophysial Hormone | CORRELATED WITH | Behavioral Abnormality |
| Behavioral Abnormality | POSITIVELY CORRELATED WITH | Schizophrenia |
Reference: